PL1771415T3 - Pochodne 2-(1H-indolilosulfanylo)-aryloaminy do stosowania w leczeniu zaburzeń afektywnych, ADHD i wysiłkowego nietrzymania moczu - Google Patents
Pochodne 2-(1H-indolilosulfanylo)-aryloaminy do stosowania w leczeniu zaburzeń afektywnych, ADHD i wysiłkowego nietrzymania moczuInfo
- Publication number
- PL1771415T3 PL1771415T3 PL05759183T PL05759183T PL1771415T3 PL 1771415 T3 PL1771415 T3 PL 1771415T3 PL 05759183 T PL05759183 T PL 05759183T PL 05759183 T PL05759183 T PL 05759183T PL 1771415 T3 PL1771415 T3 PL 1771415T3
- Authority
- PL
- Poland
- Prior art keywords
- indolylsulfanyl
- adhd
- pain
- treatment
- urinary incontinence
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58855504P | 2004-07-16 | 2004-07-16 | |
| DKPA200401121 | 2004-07-16 | ||
| US69173605P | 2005-06-17 | 2005-06-17 | |
| DKPA200500893 | 2005-06-17 | ||
| EP05759183A EP1771415B1 (en) | 2004-07-16 | 2005-07-13 | 2- (1h-indolylsulfanyl) -aryl amine derivatives for use in the treatment of affective disorders, pain, adhd and stress urinary incontinence |
| PCT/DK2005/000491 WO2006007843A1 (en) | 2004-07-16 | 2005-07-13 | 2-(1h-indolylsulfanyl) -aryl amine derivatives for use in the treatment of affective disorders, pain, adhd and stress urinary incontinence |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1771415T3 true PL1771415T3 (pl) | 2009-06-30 |
Family
ID=39243745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05759183T PL1771415T3 (pl) | 2004-07-16 | 2005-07-13 | Pochodne 2-(1H-indolilosulfanylo)-aryloaminy do stosowania w leczeniu zaburzeń afektywnych, ADHD i wysiłkowego nietrzymania moczu |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US7678800B2 (pl) |
| EP (1) | EP1771415B1 (pl) |
| JP (1) | JP4865710B2 (pl) |
| KR (1) | KR20070036061A (pl) |
| CN (1) | CN1972911A (pl) |
| AR (1) | AR052308A1 (pl) |
| AT (1) | ATE420071T1 (pl) |
| AU (1) | AU2005263324A1 (pl) |
| BR (1) | BRPI0512073A (pl) |
| CA (1) | CA2570805C (pl) |
| CY (1) | CY1108942T1 (pl) |
| DE (1) | DE602005012272D1 (pl) |
| DK (1) | DK1771415T3 (pl) |
| EA (1) | EA011418B1 (pl) |
| ES (1) | ES2317266T3 (pl) |
| HR (1) | HRP20090112T3 (pl) |
| IL (1) | IL179924A0 (pl) |
| MX (1) | MXPA06015201A (pl) |
| NO (1) | NO20066010L (pl) |
| PL (1) | PL1771415T3 (pl) |
| PT (1) | PT1771415E (pl) |
| RS (1) | RS50804B (pl) |
| SI (1) | SI1771415T1 (pl) |
| UA (1) | UA82610C2 (pl) |
| WO (1) | WO2006007843A1 (pl) |
| ZA (1) | ZA200610162B (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR054394A1 (es) * | 2005-06-17 | 2007-06-20 | Lundbeck & Co As H | Derivados de 2- (1h-indolilsulfanil)-aril amina |
| US7629473B2 (en) | 2005-06-17 | 2009-12-08 | H. Lundbeck A/S | 2-(1H-indolylsulfanyl)-aryl amine derivatives |
| AR054393A1 (es) | 2005-06-17 | 2007-06-20 | Lundbeck & Co As H | Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos. |
| PL2044020T3 (pl) | 2006-06-16 | 2011-09-30 | H Lundbeck As | Krystaliczne postaci 4-[2-(4-metylofenylosulfanylo)-fenylo]piperydyny z równoczesnym hamowaniem wychwytu zwrotnego serotoniny i norepinefryny do leczenia bólu neuropatycznego |
| TWI432194B (zh) * | 2007-03-20 | 2014-04-01 | Lundbeck & Co As H | ４-〔２-（４-甲基苯硫基）苯基〕哌啶之新穎治療用途 |
| JP2011526267A (ja) * | 2008-07-03 | 2011-10-06 | バイエル ファーマ アクチエンゲゼルシャフト | 化合物および放射性医薬品の製造方法 |
| RU2015145162A (ru) * | 2013-11-14 | 2017-12-19 | Кэлифорниа Инститьют Оф Текнолоджи | Аккомодирующая интраокулярная линза |
| EP3083588B1 (en) | 2013-12-20 | 2020-12-09 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic compounds and their application in pharmaceuticals |
| AU2015286049B2 (en) | 2014-07-08 | 2018-03-01 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic derivatives and pharmaceutical applications thereof |
| CN108536644B (zh) * | 2015-12-04 | 2022-04-12 | 格兰菲智能科技有限公司 | 由装置端推核心入队列的装置 |
Family Cites Families (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3803143A (en) | 1969-09-08 | 1974-04-09 | Eisai Co Ltd | 6-amino alkylene 6,7-dihydro-5h-dibenzo (b,g),(1,5)thiazocines |
| US4018830A (en) | 1969-09-22 | 1977-04-19 | Merck & Co., Inc. | Phenylthioaralkylamines |
| US4055665A (en) | 1974-11-25 | 1977-10-25 | Merck & Co., Inc. | Treating arrythmia with phenylthioaralkylamines |
| US4056632A (en) | 1975-07-21 | 1977-11-01 | Burroughs Wellcome Co. | 2-Hydroxymethyl-2'-aminomethyl-diphenylsulfides and method of use |
| US4241071A (en) | 1977-01-27 | 1980-12-23 | American Hoechst Corporation | Antidepressant (α-phenyl-2-tolyl)azacycloalkanes |
| US4198417A (en) | 1979-01-10 | 1980-04-15 | American Hoechst Corporation | Phenoxyphenylpiperidines |
| DE3640475A1 (de) | 1986-11-27 | 1988-06-09 | Hoechst Sa Lab | Arzneimittel auf basis von derivaten des 3,4-diphenylpiperidins, die verwendung der derivate als arzneimittel sowie neue 3,4-diphenylpiperidinderivate und verfahren zu ihrer herstellung |
| EP0396827A1 (en) | 1989-05-09 | 1990-11-14 | SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu | 2-Phenylthiobenzylamine dervivatives and acid addition salts thereof |
| GB8912971D0 (en) | 1989-06-06 | 1989-07-26 | Wellcome Found | Halogen substituted diphenylsulfides |
| US6645969B1 (en) * | 1991-05-10 | 2003-11-11 | Aventis Pharmaceuticals Inc. | Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
| BR9206810A (pt) | 1991-11-25 | 1995-10-31 | Pfizer | Derivados de indol |
| GB9126311D0 (en) | 1991-12-11 | 1992-02-12 | Wellcome Found | Substituted diphenylsulfides |
| GB9226532D0 (en) | 1992-12-21 | 1993-02-17 | Smithkline Beecham Plc | Compounds |
| US5945425A (en) * | 1994-04-29 | 1999-08-31 | G.D. Searle & Co. | Method of using (H+ /K+)ATPase inhibitors as antiviral agents |
| ATE294778T1 (de) | 1995-01-23 | 2005-05-15 | Daiichi Suntory Pharma Co Ltd | Verbesserung oder heilung von durch ischämischen krankheiten hervorgerufenen symtomen und dafür verwendbare phenylpiperidinverbingungen |
| ES2128281T1 (es) | 1995-11-06 | 1999-05-16 | Gist Brocades Bv | Proceso de desesterificacion. |
| CZ293595A3 (cs) | 1995-11-09 | 1999-12-15 | Farmak A. S. | Deriváty N,N-dimethyl-2-(arylthio)benzylaminu, jejich soli, způsoby jejich přípravy a jejich použití v léčivých přípravcích |
| US5912256A (en) | 1996-06-20 | 1999-06-15 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
| PT923548E (pt) | 1996-08-27 | 2003-06-30 | Wyeth Corp | 4-aminoetoxi-indolos como agonistas d2 da dopaminae como ligandos da 5ht1a |
| GB9725953D0 (en) | 1997-12-08 | 1998-02-04 | Pfizer Ltd | Compounds useful in therapy |
| DE19756036A1 (de) * | 1997-12-17 | 1999-06-24 | Merck Patent Gmbh | Amid- und Harnstoffderivate |
| US6333146B1 (en) * | 1999-03-10 | 2001-12-25 | Fuji Photo Film Co., Ltd. | Methine compound and silver halide photographic material containing the same |
| BR0009421A (pt) | 1999-04-02 | 2002-03-26 | Icos Corp | Inibidores de ligação lfa-1 aos icams e uso dos mesmos |
| JP2002543173A (ja) | 1999-04-30 | 2002-12-17 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルベニア | セロトニン輸送体のためのｓｐｅｃｔ画像化剤 |
| JP2003528810A (ja) | 1999-08-04 | 2003-09-30 | ミレニアム ファーマスーティカルズ インク | メラノコルチン−４受容体結合化合物及びその使用方法 |
| US6410736B1 (en) | 1999-11-29 | 2002-06-25 | Pfizer Inc. | Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| MXPA02003793A (es) | 1999-10-13 | 2002-09-30 | Pfizer Prod Inc | Nuevos derivados de biarileter utiles como inhibidores de la recaptacion de monoaminas. |
| CZ20022319A3 (cs) | 1999-12-30 | 2002-10-16 | H. Lundbeck A/S | Substituovaná fenylpiperazinová sloučenina a farmaceutický prostředek, který ji obsahuje |
| CA2395867A1 (en) | 1999-12-30 | 2001-07-12 | Kim Andersen | Phenylpiperazinyl derivatives |
| DK1246817T3 (da) | 1999-12-30 | 2004-10-18 | Lundbeck & Co As H | 4-Phenyl-1-piperazinyl, -piperidinyl og - tetrahydropyridyl derivater |
| EP1857109B1 (en) * | 2000-02-29 | 2010-09-22 | MediQuest Therapeutics, Inc. | Inhibitors of melanocyte tyrosinase as topical skin lighteners |
| CN1251671C (zh) * | 2000-05-19 | 2006-04-19 | 武田药品工业株式会社 | β分泌酶抑制剂 |
| US6455738B1 (en) * | 2000-07-13 | 2002-09-24 | Rhodia Chimie | Process for the sulfonation of an aromatic compound |
| US20030187023A1 (en) * | 2000-07-17 | 2003-10-02 | Keiji Kubo | Sulfone derivatives, process for their production and use thereof |
| AU2001279955A1 (en) * | 2000-08-18 | 2002-03-04 | Sterix Limited | 2-substituted estradiol derivative for inhibiting superoxid dismutase |
| IL154467A0 (en) * | 2000-09-01 | 2003-09-17 | Fmc Corp | 1,4-disubstituted benzenes as insecticides |
| WO2002020463A2 (en) * | 2000-09-05 | 2002-03-14 | Tularik Inc. | Fxr modulators |
| EP1193268A1 (en) * | 2000-09-27 | 2002-04-03 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases |
| US6852816B2 (en) * | 2000-10-06 | 2005-02-08 | Biocompatibles Uk Limited | Zwitterionic polymers |
| AU2002213467A1 (en) * | 2000-10-11 | 2002-04-22 | Chemocentryx, Inc. | Modulation of ccr4 function |
| AU1502702A (en) | 2000-11-14 | 2002-05-27 | Merck Patent Gmbh | Novel uses of combined 5-HT<sub>1A</sub> agonists and serotonin reuptake inhibitors |
| AR035521A1 (es) * | 2000-12-22 | 2004-06-02 | Lundbeck & Co As H | Derivados de 3-indolina y composicion farmaceutica que los comprende |
| US6436938B1 (en) | 2001-01-22 | 2002-08-20 | Pfizer Inc. | Combination treatment for depression |
| WO2002062766A2 (en) | 2001-02-07 | 2002-08-15 | Millennium Pharmaceuticals, Inc. | Melanocortin-4 receptor binding compounds and methods of use thereof |
| MXPA03011244A (es) | 2001-06-07 | 2004-02-27 | Hoffmann La Roche | Nuevos derivados de indol con afinidad por el receptor 5-ht6. |
| JPWO2002100833A1 (ja) * | 2001-06-12 | 2004-09-24 | 住友製薬株式会社 | Ｒｈｏキナーゼ阻害剤 |
| UA81749C2 (uk) * | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
| US7064139B2 (en) * | 2001-10-29 | 2006-06-20 | Uniroyal Chemical Company, Inc. | Method for treating retroviral infections |
| PL369952A1 (pl) * | 2001-11-14 | 2005-05-02 | Schering Corporation | Ligandy receptora kanabinoidowego |
| EP1458704A1 (en) | 2001-12-21 | 2004-09-22 | H. Lundbeck A/S | Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors |
| US8048408B2 (en) * | 2002-01-16 | 2011-11-01 | Biocompatibles Uk Limited | Polymer conjugates |
| US20050261298A1 (en) * | 2002-01-18 | 2005-11-24 | David Solow-Cordero | Methods of treating conditions associated with an Edg-7 receptor |
| BR0308126A (pt) * | 2002-03-04 | 2005-01-04 | Japan Science & Tech Agency | Composto de fosfonamida, processo para produzir o mesmo, agente e processo para extrair um ìon de metal de terra rara, e, processo para retro-extrair um ìon de metal de terra rara |
| CA2480518C (en) * | 2002-03-29 | 2016-07-19 | Massachusetts Institute Of Technology | Light emitting device including semiconductor nanocrystals |
| DE10217006A1 (de) * | 2002-04-16 | 2003-11-06 | Merck Patent Gmbh | Substituierte Indole |
| WO2004000807A1 (en) * | 2002-06-19 | 2003-12-31 | Schering Corporation | Cannabinoid receptor agonists |
| TW200401641A (en) * | 2002-07-18 | 2004-02-01 | Wyeth Corp | 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands |
| MXPA05002836A (es) * | 2002-09-17 | 2005-05-27 | Hoffmann La Roche | Indoles 2,4-sustituidos y su uso como moduladores 5-ht6. |
| CA2496765A1 (en) * | 2002-09-17 | 2004-04-01 | F. Hoffmann-La Roche Ag | 2,7-substituted indoles and their use as 5-ht6 modulators |
| EP1402888A1 (en) * | 2002-09-18 | 2004-03-31 | Jerini AG | The use of substituted carbocyclic compounds as rotamases inhibitors |
| US20040266732A1 (en) * | 2002-09-20 | 2004-12-30 | Jorge Galvez | Therapeutic agents, methods, and treatments |
| ATE344030T1 (de) * | 2002-10-18 | 2006-11-15 | Hoffmann La Roche | 4-piperazinylbenzolsulfonyl-indole mit 5-ht6 rezeptor-affinität |
| US20040137389A1 (en) * | 2002-12-19 | 2004-07-15 | Kouta Fukui | Heat-developable light-sensitive material |
| US7321001B2 (en) * | 2002-12-20 | 2008-01-22 | Amgen Inc. | Asthma and allergic inflammation modulators |
| CN1512264B (zh) * | 2002-12-27 | 2010-05-26 | 富士胶片株式会社 | 卤化银彩色照相感光材料 |
| DE10300098A1 (de) * | 2003-01-07 | 2004-07-15 | Bayer Ag | Kupfer-Carben-Komplexe und ihre Verwendung |
| EP2267049A1 (en) * | 2003-02-05 | 2010-12-29 | Biocompatibles UK Limited | Block copolymers |
| AR043633A1 (es) * | 2003-03-20 | 2005-08-03 | Schering Corp | Ligandos de receptores de canabinoides |
| US7893096B2 (en) * | 2003-03-28 | 2011-02-22 | Novartis Vaccines And Diagnostics, Inc. | Use of small molecule compounds for immunopotentiation |
| US7244763B2 (en) * | 2003-04-17 | 2007-07-17 | Warner Lambert Company Llc | Compounds that modulate PPAR activity and methods of preparation |
| EP1671962A1 (en) * | 2003-10-10 | 2006-06-21 | Ono Pharmaceutical Co., Ltd. | Novel fused heterocyclic compound and use thereof |
| US7229751B2 (en) * | 2003-11-20 | 2007-06-12 | Konica Minolta Medical & Graphic, Inc. | Silver salt photothermographic dry imaging material and image forming method using the same |
| WO2005060711A2 (en) * | 2003-12-19 | 2005-07-07 | Elixir Pharmaceuticals, Inc. | Methods of treating a disorder |
| AU2004303461B2 (en) * | 2003-12-23 | 2011-04-28 | H. Lundbeck A/S | 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI |
| SE528250C2 (sv) * | 2004-02-27 | 2006-10-03 | Calignum Technologies Ab | Komposition innefattande en initiator och ett förfarande för att behandla trä med kompositionen |
| JP4569142B2 (ja) * | 2004-03-22 | 2010-10-27 | コニカミノルタホールディングス株式会社 | 表示素子 |
| JP4448730B2 (ja) * | 2004-04-20 | 2010-04-14 | 富士フイルム株式会社 | 感光性組成物、該感光性組成物に用いられる化合物及び該感光性組成物を用いたパターン形成方法 |
| US20090156471A1 (en) | 2004-07-15 | 2009-06-18 | Ramot At Tel Aviv University Ltd. | Use of anti-amyloid agents for treating and typing pathogen infections |
| WO2006098380A1 (ja) | 2005-03-15 | 2006-09-21 | Fujifilm Corporation | 円盤状化合物を用いた表面処理法、表面処理用（潤滑）組成物及び表面処理された物品 |
-
2005
- 2005-07-12 AR ARP050102877A patent/AR052308A1/es not_active Application Discontinuation
- 2005-07-13 EP EP05759183A patent/EP1771415B1/en active Active
- 2005-07-13 DK DK05759183T patent/DK1771415T3/da active
- 2005-07-13 DE DE602005012272T patent/DE602005012272D1/de active Active
- 2005-07-13 AU AU2005263324A patent/AU2005263324A1/en not_active Abandoned
- 2005-07-13 EA EA200602180A patent/EA011418B1/ru not_active IP Right Cessation
- 2005-07-13 ES ES05759183T patent/ES2317266T3/es active Active
- 2005-07-13 CA CA2570805A patent/CA2570805C/en not_active Expired - Fee Related
- 2005-07-13 PL PL05759183T patent/PL1771415T3/pl unknown
- 2005-07-13 PT PT05759183T patent/PT1771415E/pt unknown
- 2005-07-13 SI SI200530606T patent/SI1771415T1/sl unknown
- 2005-07-13 MX MXPA06015201A patent/MXPA06015201A/es not_active Application Discontinuation
- 2005-07-13 WO PCT/DK2005/000491 patent/WO2006007843A1/en active Application Filing
- 2005-07-13 KR KR1020067025769A patent/KR20070036061A/ko not_active Application Discontinuation
- 2005-07-13 ZA ZA200610162A patent/ZA200610162B/en unknown
- 2005-07-13 UA UAA200612493A patent/UA82610C2/uk unknown
- 2005-07-13 JP JP2007520664A patent/JP4865710B2/ja not_active Expired - Fee Related
- 2005-07-13 BR BRPI0512073-0A patent/BRPI0512073A/pt not_active IP Right Cessation
- 2005-07-13 CN CNA200580020862XA patent/CN1972911A/zh active Pending
- 2005-07-13 RS RSP-2009/0070A patent/RS50804B/sr unknown
- 2005-07-13 AT AT05759183T patent/ATE420071T1/de active
- 2005-07-13 US US11/629,043 patent/US7678800B2/en not_active Expired - Fee Related
-
2006
- 2006-12-07 IL IL179924A patent/IL179924A0/en unknown
- 2006-12-27 NO NO20066010A patent/NO20066010L/no not_active Application Discontinuation
-
2009
- 2009-02-23 HR HR20090112T patent/HRP20090112T3/xx unknown
- 2009-03-31 CY CY20091100373T patent/CY1108942T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE602005012272D1 (de) | 2009-02-26 |
| PT1771415E (pt) | 2009-03-16 |
| DK1771415T3 (da) | 2009-02-23 |
| RS50804B (sr) | 2010-08-31 |
| AR052308A1 (es) | 2007-03-14 |
| US7678800B2 (en) | 2010-03-16 |
| BRPI0512073A (pt) | 2008-02-06 |
| EA200602180A1 (ru) | 2007-04-27 |
| CA2570805C (en) | 2010-08-24 |
| EA011418B1 (ru) | 2009-02-27 |
| NO20066010L (no) | 2006-12-27 |
| US20080027074A1 (en) | 2008-01-31 |
| AU2005263324A1 (en) | 2006-01-26 |
| UA82610C2 (uk) | 2008-04-25 |
| WO2006007843A1 (en) | 2006-01-26 |
| ZA200610162B (en) | 2008-06-25 |
| CY1108942T1 (el) | 2014-07-02 |
| EP1771415B1 (en) | 2009-01-07 |
| CA2570805A1 (en) | 2006-01-26 |
| ATE420071T1 (de) | 2009-01-15 |
| MXPA06015201A (es) | 2007-03-15 |
| SI1771415T1 (sl) | 2009-04-30 |
| HRP20090112T3 (en) | 2009-03-31 |
| ES2317266T3 (es) | 2009-04-16 |
| KR20070036061A (ko) | 2007-04-02 |
| CN1972911A (zh) | 2007-05-30 |
| JP2008506640A (ja) | 2008-03-06 |
| IL179924A0 (en) | 2007-05-15 |
| JP4865710B2 (ja) | 2012-02-01 |
| EP1771415A1 (en) | 2007-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL179924A0 (en) | 2 - (1h-indolylsulfanyl) - aryl amine derivatives for use in the treatment of affective disorders, pain adhd and stress urinary incontinence | |
| PL1849773T3 (pl) | Pochodne piperazyny do leczenia nietrzymania moczu i bólu | |
| IL230241A (en) | Retinal history and methods of using them to treat visual irregularities | |
| IL178775A (en) | Pharmaceuticals containing glucocorticoid for use in the treatment of disorders requiring acute glucocorticoid therapy | |
| EP1879578A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE | |
| EP2073752A4 (en) | IMPLANTABLE DEVICES FOR THE TREATMENT OF INCONTINENCE, AND METHODS OF USE | |
| IL188922A0 (en) | Benzoquinazoline derivatives and their use in treating bone disorders | |
| EP2173275A4 (en) | APPARATUS AND METHOD FOR TREATING INCONTINENCE TO EFFORT | |
| PL1761266T3 (pl) | Związki, preparaty i sposoby leczenia lub zapobiegania procesom zapalnym skóry | |
| HK1103282A1 (en) | Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders | |
| IL183656A0 (en) | Indenyl derivatives and use thereof for the treatment of neurological disorders | |
| IL183557A0 (en) | The use of the non-opiate analgesic drug flupirtine for the treatment of overactive bladder and associated diseases including urge incontinence, urinary flow problems as a result of prostate hyperplasia and irritable bowl syndrome | |
| IL178827A0 (en) | Use of reboxetine for the treatment of pain | |
| EP1796675A4 (en) | COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DISEASES | |
| EP1933853A4 (en) | TREATMENT OF TISSUE DISTRACTION AND COMPOSITION FOR APPLYING THEREOF | |
| IL193943A0 (en) | The use of beta- aminoalcohols for the treatment of inflammatory disorders and pain | |
| WO2008002544A3 (en) | Unit dosage forms of temozolomide | |
| IL162776A0 (en) | 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence | |
| IL193944A0 (en) | The use beta-aminoalcohols for the treatment of inflammatory disorders and pain | |
| EP1879519A4 (en) | IMPLANTABLE SLINGS FOR TREATING INCONTINENCE AND USE METHOD THEREFOR | |
| GB0419828D0 (en) | The treatment of inflammatroy disorders and pain | |
| EP1858557A4 (en) | METHODS AND COMPOSITIONS FOR MODULATING BODY WEIGHT AND TREATING WEIGHT RELATED DISORDERS AND DISEASES | |
| EP1711054A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF PAINFUL SUFFERINGS | |
| ZA200803239B (en) | Treatment of stress urinary incontinence and mixed urinary incontinence | |
| ZA200710213B (en) | Vaccine composition and methods for the treatment of urinary incontinence |